These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1454738)

  • 1. Prescribing in heart disease.
    Dunn F; Lip G
    Practitioner; 1992 Jun; 236(1515):669-71. PubMed ID: 1454738
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac P2X(4) receptors: targets in ischemia and heart failure?
    Yang R; Liang BT
    Circ Res; 2012 Aug; 111(4):397-401. PubMed ID: 22859669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can metabolic manipulation reverse myocardial dysfunction?
    Cokkinos DV
    Eur Heart J; 2001 Dec; 22(23):2138-9. PubMed ID: 11913472
    [No Abstract]   [Full Text] [Related]  

  • 4. Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias.
    Stone PH
    Cardiol Clin; 2008 Nov; 26(4):603-14. PubMed ID: 18929234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].
    Ol'binskaia LI; Sizova ZhM; Alekperov EE
    Ter Arkh; 1994; 66(8):30-2. PubMed ID: 7985149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroendocrine-immune interface gone awry in aldosteronism.
    Weber KT
    Cardiovasc Res; 2004 Dec; 64(3):381-3. PubMed ID: 15537489
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation and role of the presynaptic and myocardial Na+/H+ exchanger NHE1: effects on the sympathetic nervous system in heart failure.
    Leineweber K; Heusch G; Schulz R
    Cardiovasc Drug Rev; 2007; 25(2):123-31. PubMed ID: 17614935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems of drug dosage in patients with cardiac insufficiency].
    Follath F
    Ther Umsch; 1984 Feb; 41(2):134-7. PubMed ID: 6369616
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of captopril in therapeutic combinations].
    Alföldi S
    Acta Pharm Hung; 1997 Jul; 67(4):149-53. PubMed ID: 9289943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients.
    Ranchord AM; Harding SA; Pidgeon G
    Intern Med J; 2008 May; 38(5):361-4. PubMed ID: 18402563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythropoietin in the treatment of heart failure and ischemia].
    Lewartowski B
    Kardiol Pol; 2007 Feb; 65(2):192-7. PubMed ID: 17366366
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pumpan treatment of ischemic heart disease with heart failure in elderly].
    Konev IuV; Ivanov AN
    Klin Med (Mosk); 1999; 77(11):42-3. PubMed ID: 10635633
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of opinion leader-endorsed evidence summaries on the quality of prescribing for patients with cardiovascular disease: a randomized controlled trial.
    Majumdar SR; Tsuyuki RT; McAlister FA
    Am Heart J; 2007 Jan; 153(1):22.e1-8. PubMed ID: 17174632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine and its role in cardiovascular disease.
    Retter AS
    Heart Dis; 1999; 1(2):108-13. PubMed ID: 11720611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones and cardiovascular outcomes in type 2 diabetes.
    Singh S; Furberg CD
    Heart; 2009 Jan; 95(1):1-3. PubMed ID: 18753156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dilzem-retard efficiency in patients with ischemic heart disease and heart failure].
    Gadzhiev AN
    Klin Med (Mosk); 2002; 80(6):45-8. PubMed ID: 12138803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gopten (trandolapril) in the treatment of chronic heart failure in patients with ischemic heart disease].
    Kakhnovskiĭ IM; Fomina IG; Ostroumov EL; Lepeshkov VM; Gaĭdamakina NE; Kaveshnikova OV; Markova ZS; Lugovaia EL
    Ter Arkh; 1998; 70(8):29-33. PubMed ID: 9770740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the optimal medical management of ischemic heart failure?
    Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M
    Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiostatin: drying out the roots in cardiac muscle.
    Frank KF; Müller-Ehmsen J
    Heart; 2009 Feb; 95(4):269-70. PubMed ID: 19095713
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure.
    Lesnefsky EJ; Moghaddas S; Tandler B; Kerner J; Hoppel CL
    J Mol Cell Cardiol; 2001 Jun; 33(6):1065-89. PubMed ID: 11444914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.